121 related articles for article (PubMed ID: 12192718)
21. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment.
Hedrick J
Paediatr Drugs; 2003; 5 Suppl 1():35-46. PubMed ID: 14632104
[TBL] [Abstract][Full Text] [Related]
22. The use of systemic and topical fluoroquinolones.
Bradley JS; Jackson MA; ;
Pediatrics; 2011 Oct; 128(4):e1034-45. PubMed ID: 21949152
[TBL] [Abstract][Full Text] [Related]
23. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
Morrissey I; Colclough A; Northwood J
Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
[TBL] [Abstract][Full Text] [Related]
24. [Impact of fluoroquinolone use on multidrug-resistant bacteria emergence].
Nseir S; Ader F; Marquette CH; Durocher A
Pathol Biol (Paris); 2005; 53(8-9):470-5. PubMed ID: 16176863
[TBL] [Abstract][Full Text] [Related]
25. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
26. The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam.
Parry CM
Trans R Soc Trop Med Hyg; 2004 Jul; 98(7):413-22. PubMed ID: 15138078
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
28. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
Fraise AP
J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
[TBL] [Abstract][Full Text] [Related]
29. Appropriate use of fluoroquinolones in children.
Principi N; Esposito S
Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
[TBL] [Abstract][Full Text] [Related]
30. The use of fluoroquinolones in children: recent advances.
Velissariou IM
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):853-60. PubMed ID: 17140360
[TBL] [Abstract][Full Text] [Related]
31. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
Iannini PB
Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial safety: focus on fluoroquinolones.
Owens RC; Ambrose PG
Clin Infect Dis; 2005 Jul; 41 Suppl 2():S144-57. PubMed ID: 15942881
[TBL] [Abstract][Full Text] [Related]
33. [New fluoroquinolones in urology].
Derevianko II; Hefedova LA
Urologiia; 2004; (4):27-32. PubMed ID: 15457949
[TBL] [Abstract][Full Text] [Related]
34. Clinical studies of garenoxacin.
Takagi H; Tanaka K; Tsuda H; Kobayashi H
Int J Antimicrob Agents; 2008 Dec; 32(6):468-74. PubMed ID: 18790608
[TBL] [Abstract][Full Text] [Related]
35. Viral and atypical bacterial infections in the outpatient pediatric cystic fibrosis clinic.
Olesen HV; Nielsen LP; Schiotz PO
Pediatr Pulmonol; 2006 Dec; 41(12):1197-204. PubMed ID: 17058280
[TBL] [Abstract][Full Text] [Related]
36. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
[TBL] [Abstract][Full Text] [Related]
37. Will fluoroquinolones ever be recommended for common infections in children?
Schaad UB
Pediatr Infect Dis J; 2007 Oct; 26(10):865-7. PubMed ID: 17901790
[No Abstract] [Full Text] [Related]
38. Fluoroquinolones in children: update of the literature.
Bacci C; Galli L; de Martino M; Chiappini E
J Chemother; 2015 Oct; 27(5):257-65. PubMed ID: 26099190
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.
van Ewijk BE; van der Zalm MM; Wolfs TF; Fleer A; Kimpen JL; Wilbrink B; van der Ent CK
Pediatrics; 2008 Dec; 122(6):1171-6. PubMed ID: 19047230
[TBL] [Abstract][Full Text] [Related]
40. The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?
Mandell LA; Peterson LR; Wise R; Hooper D; Low DE; Schaad UB; Klugman KP; Courvalin P
Clin Infect Dis; 2002 Sep; 35(6):721-7. PubMed ID: 12203170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
